// COMPANY
Myriad Genetics
SECTOR BIOTECHMENTIONS 1LAST SEEN OCTOBER 21, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·OCTOBER 21, 2026
“Labcorp (NYSE: LH) agreed to buy the prenatal health testing business of Myriad Genetics (Nasdaq: MYGN) for $210m in cash.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.